New initiative to strengthen Danish pharma production

The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry.

"It is a really positive move from the government, which has the potential to make a big difference in terms of strengthening expansions and attracting life science production to Denmark. These are concrete initiatives that will make it easier for companies to navigate complex processes involving many authorities. It will increase transparency, reduce uncertainties and thus make it more attractive to invest in Denmark," says Ida Sofie Jensen, chief executive of Lif - the Pharmaceutical Industry Association of Denmark, about the government's new growth plans.

Life science production is a huge strength for Denmark and is the foundation for sharply increasing exports, the organization noted. Today, the sector consists of more than 1,600 companies and more than 50,000 employees, and it contributes to around 20% of total Danish goods exports – in 2022 the total export of life science products was 175 billion kroner ($25.37 billion).